Latest Breaking News On - Head of the ophthalmic research lab - Page 1 : comparemela.com

Kiora Pharmaceuticals (KPRX) Reports Additional Clinical Data for KIO-301

Kiora Pharmaceuticals (KPRX) Reports Additional Clinical Data for KIO-301
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric danielsRobert james cassonUniversity of adelaideAssociation for researchHead of the ophthalmic research labKiora pharmaceuticals incKiora pharmaceuticalsProfessor robert james cassonOphthalmic research labChief development officerOpen innovation

Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa

Kiora Pharmaceuticals, Inc. , announced additional data from ABACUS-1, the Phase I/II clinical trial in patients with retinitis pigmentosa showing KIO-301 significantly increased brain activity,.

United statesRobert james cassonEric danielsUniversity of adelaideKiora pharmaceuticalsAssociation for researchKiora pharmaceuticals incHead of the ophthalmic research labCalifornia newsfile corpProfessor robert james cassonOphthalmic research labChief development officerOpen innovationPrivate securities litigation reform actAnnual report